Acquisition history Former Nexgen Pharma profile notes an acquisition by LGM Pharma in July 2020, indicating potential alignment shifts, integration opportunities, or post-merger services for contract development and manufacturing of Rx, OTC products, and dietary supplements.

Contract manufacturing Specializes in development and manufacturing for Rx, OTC, and custom dietary supplements, suggesting opportunities to pitch expanded CDMO services, scale-up capabilities, and formulation partnerships with companies seeking reliable manufacturing partners.

Financial scope Reported annual revenue in the range of $100M–$250M with 51–200 employees, indicating mid-market scale and potential for growing service engagements, value-based pricing discussions, and capacity-fit opportunities.

Quality and service Emphasizes rigorous quality and customer service, presenting a lead for sales conversations around quality systems, regulatory support, and long-term supply chain reliability as differentiators in competitive CDMO landscapes.

Digital footprint Tech stack includes AWS, WordPress/WooCommerce, analytics, and performance tools, suggesting readiness for digital engagement, e-commerce style client portals, and data-driven marketing collaboration to streamline program management.